## NVMI: Nova Ltd. - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.3% in lower entry zone (3.0-6.0%), top quartile (79th pct) cross-sectional ranking. Short-term MRS_5 (1.2%) confirms momentum alignment.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($308.07)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 124.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Tudor Investment Cor: 81.6% (+100.0%)
- FMR, LLC: 10.0% (+1.0%)
- Wasatch Advisors LP: 6.6% (-11.8%)
- Harel Insurance Inve: 4.9% (+6.4%)
- Migdal Insurance & F: 4.8% (-2.9%)

### Key Risks

1. High beta (1.84) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.01 suggests fair value with growth premium. Forward P/E 34.8x stretched relative to 11% growth. Quality metrics strong (ROE 24%, margin 29%). Balance sheet: strong liquidity (4.6x). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $9.9B |
| Beta | 1.84 |
| 52W Range | $154.00 - $361.32 |
| Short Interest | 4.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.01 |
| Forward P/E | 34.8 |
| Current P/E | 38.6 |
| YoY Growth | 10.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 3.3% (minimal 5-day change). Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 79th percentile. MRS_5 at 1.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.78), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.30% (CS: 80) | Strong |
| RSI_14 | 60.6 | Neutral |
| MACD Histogram | 4.78 | Bullish |
| vs SMA20 | 1.093x | Above |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 1.303x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $334.83
- **Stop Loss:** $308.07 (8.0% risk)
- **Target:** $374.97 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 44
- **Position Value:** $14,732.52
- **Portfolio %:** 14.73%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2026-02-12 (Est: $2.13)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.15 | $2.16 | +0.5% |
| 2025Q2 | $2.06 | $2.20 | +6.5% |
| 2025Q1 | $2.09 | $2.18 | +4.4% |
| 2024Q4 | $1.82 | $1.94 | +6.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*